Literature DB >> 23933568

Metastatic breast carcinoma induces vascular endothelial dysfunction in Balb-c mice: Role of the tumor necrosis factor-α and NADPH oxidase.

Selvinaz Dalaklioglu1, Arda Tasatargil, Sule Kale, Gamze Tanriover, Sayra Dilmac, Nuray Erin.   

Abstract

Although the oxidative stress and inflammation are closely related with breast cancer, there is no study directly examining the possible changes in vascular functions in the presence of breast carcinoma. The goal of the present study was to evaluate changes in vascular reactivity in tumor-bearing mice. In this study, highly metastatic breast carcinoma cells which were derived from liver or brain metastasis of 4T1 murine breast carcinoma (4TLM and 4TBM, respectively), and 67NR cells which were tumorigenic but non-metastatic cells were used. Female Balb-c mice 8-10weeks old were divided into following groups: (1) control, (2) injected with 67NR, (3) injected with 4TLM, and (4) injected with 4TBM orthotopically. Thoracic aorta was removed 23-25days after injection of tumor cells. Isometric tension studies were performed in response to potassium chloride (KCl), phenylephrine (Phe), acetylcholine (ACh, an endothelium-dependent vasodilator), and sodium nitroprusside (SNP, an endothelium-independent vasodilator). Endothelial nitric oxide synthase (eNOS), phosphorylated eNOS (Ser 1177) (p-eNOS), gp91(phox), and tumor necrosis factor-α (TNF-α) expressions in aortic tissues were demonstrated by immunohistochemistry. The level of TNF-α in vascular tissue was measured by ELISA. The presence of tumor was resulted in significant inhibition of response to ACh in both 4TLM and 4TBM injected mice, but not 67NR injected mice. Furthermore, both KCl and Phe-induced contraction of thoracic aorta was not changed significantly in tumor-bearing animals. eNOS and p-eNOS expressions decreased while gp91(phox) and TNF-α expressions increased in endothelium of 4TLM and 4TBM mice compared to 67NR injected and control mice. Moreover, TNF-α levels of thoracic aorta in mice with metastatic breast carcinoma were significantly higher than that of 67NR mice. Tumor-induced endothelial dysfunction determined by ACh-induced relaxation improved by superoxide dismutase (SOD), apocynin (a NADPH oxidase inhibitor), and infliximab (a TNF-α monoclonal antibody). The findings of this study suggest that the presence of metastatic breast carcinoma may cause a significant reduction in endothelium-dependent relaxation of thoracic aorta via NADPH oxidase-mediated oxidative stress and TNF-α production.
© 2013.

Entities:  

Keywords:  Breast carcinoma; Endothelial dysfunction; NADPH oxidase; TNF-α

Mesh:

Substances:

Year:  2013        PMID: 23933568     DOI: 10.1016/j.vph.2013.07.008

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  5 in total

1.  Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.

Authors:  Amal Hofni; Basim A Shehata Messiha; Safwat A Mangoura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-11       Impact factor: 3.000

2.  Anti-tumor Necrosis Factor Alpha (Infliximab) Attenuates Apoptosis, Oxidative Stress, and Calcium Ion Entry Through Modulation of Cation Channels in Neutrophils of Patients with Ankylosing Spondylitis.

Authors:  Yunus Ugan; Mustafa Nazıroğlu; Mehmet Şahin; Mehmet Aykur
Journal:  J Membr Biol       Date:  2016-03-08       Impact factor: 1.843

3.  Alterations in NO- and PGI2- dependent function in aorta in the orthotopic murine model of metastatic 4T1 breast cancer: relationship with pulmonary endothelial dysfunction and systemic inflammation.

Authors:  E Buczek; A Denslow; L Mateuszuk; B Proniewski; T Wojcik; B Sitek; A Fedorowicz; A Jasztal; E Kus; A Chmura-Skirlinska; R Gurbiel; J Wietrzyk; S Chlopicki
Journal:  BMC Cancer       Date:  2018-05-22       Impact factor: 4.430

4.  Increased Risk of Cardiovascular Death in Breast Cancer Patients Without Chemotherapy or (and) Radiotherapy: A Large Population-Based Study.

Authors:  Tianwang Guan; Hanbin Zhang; Jinming Yang; Wenrui Lin; Kenie Wang; Miao Su; Weien Peng; Yemin Li; Yanxian Lai; Cheng Liu
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

5.  Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment.

Authors:  Radoslaw Bednarek; Anna Selmi; Dagmara Wojkowska; Kamil Karolczak; Marcin Popielarski; Marta Stasiak; Moro O Salifu; Anna Babinska; Maria Swiatkowska
Journal:  Breast Cancer Res Treat       Date:  2019-10-24       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.